Autologous CD34+Cell Therapy for Refractory Angina: 12 Month Results of the Phase II ACT34-CMI Study

被引:0
|
作者
Losordo, Douglas W. [1 ]
Henry, Tim [2 ]
Schatz, Richard A. [3 ]
Lee, Joon Sup [4 ]
Costa, Marco [5 ]
Bass, Theodore [5 ]
Schaer, Gary [6 ]
Niederman, Alan [7 ]
Mendelsohn, Farrell [8 ]
Davidson, Charles [1 ]
Waksman, Ron [9 ]
Soukas, Peter A. [10 ]
Simon, Daniel [5 ]
Chronos, Nicolas [11 ]
Fortuin, F. David [12 ]
Huang, Paul P. [13 ]
Weintraub, Neal [14 ]
Yeung, Alan [15 ]
Rosenfield, Kenneth [16 ]
Wong, S. Chiu [17 ]
Taussig, Andrew [18 ]
Rava, Amish N. [19 ]
Sherman, Warren [20 ]
Kereiakes, Dean [21 ]
Strumpf, Robert K. [22 ]
Port, Steven [23 ]
Pieper, Karen [24 ]
Adams, Peter X. [25 ]
Harrington, Robert [24 ]
机构
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Minneapolis Heart Insitute, Minneapolis, MN USA
[3] Scripps Green Hosp, San Diego, CA USA
[4] UPMC, Pittsburgh, PA USA
[5] Case Western Reserve Univ, Cleveland, OH 44106 USA
[6] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[7] Holy Cross Hosp, Ft Lauderdale, FL USA
[8] Cardiol PC, Birmingham, AL USA
[9] Washington Hosp Ctr, Washington, DC 20010 USA
[10] St Elizabeths, Boston, MA USA
[11] St Josephs Rsch Inst, Atlanta, GA USA
[12] Mayo Clin, Scottsdale, AZ USA
[13] Swedish Seattle Hosp, Seattle, WA USA
[14] Univ Cincinnati, Med Ctr, Univ Iowa Healthcare, Cincinnati, OH 45267 USA
[15] Stanford Univ, Stanford, CA 94305 USA
[16] Massachusetts Gen Hosp, Boston, MA 02114 USA
[17] Cornell Univ, Ithaca, NY USA
[18] Florida Hosp, Orlando, FL USA
[19] Univ Wisconsin, Madison, WI USA
[20] Columbia Univ, New York, NY USA
[21] Lindner Clin Trial Ctr, Cincinnati, OH USA
[22] Arizona Heart, Phoenix, AZ USA
[23] St Lukes, Kansas City, MO USA
[24] Duke Clin Rsch Inst, Durham, NC USA
[25] Baxter Healthcare Corp, Deerfield, IL 60015 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S1132 / S1132
页数:1
相关论文
共 50 条
  • [31] A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia
    Losordo, Douglas W.
    Kibbe, Melina R.
    Mendelsohn, Farrell
    Marston, William
    Driver, Vickie R.
    Sharafuddin, Melhem
    Teodorescu, Victoria
    Wiechmann, Bret N.
    Thompson, Charles
    Kraiss, Larry
    Carman, Teresa
    Dohad, Suhail
    Huang, Paul
    Junge, Candice E.
    Story, Kenneth
    Weistroffer, Tara
    Thorne, Tina M.
    Millay, Meredith
    Runyon, John Paul
    Schainfeld, Robert
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (06) : 821 - 830
  • [32] A phase I/II, single-blind, dose-escalation, clinical trial of autologous CD34+cell transplantation in intractable patients with chronic critical limb ischemia
    Kawamoto, A.
    Katayama, M.
    Handa, N.
    Kinoshita, M.
    Kihara, Y.
    Asahara, T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 500 - 501
  • [33] PEG-Filgrastim for Autologous Peripheral CD34+STEM CELL Collection in Pediatric Oncological PATIENTS: A PHASE II STUDY
    Cesaro, Simone
    Tridello, Gloria
    Zanazzo, Andrea Giulio
    Frenos, Stefano
    Messina, Chiara
    Dallorso, Sandro
    BLOOD, 2008, 112 (11) : 806 - 806
  • [34] Autologous CD34+Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction
    Henry, Timothy D.
    Merz, C. Noel Bairey
    Wei, Janet
    Corban, Michel T.
    Quesada, Odayme
    Joung, Sandy
    Kotynski, Christine L.
    Wang, Jian
    Lewis, Michelle
    Schumacher, Ann M.
    Bartel, Ronnda L.
    Takagi, Hiroshi
    Shah, Vishal
    Lee, Anna
    Sietsema, William K.
    Losordo, Douglas W.
    Lerman, Amir
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (02) : 130 - 137
  • [35] Results of a phase II study on the use of peg-filgrastim for the collection of autologous peripheral CD34+stem cells in paediatric patients
    Cesaro, S.
    Zanazzo, G. A.
    Tridello, G.
    Frenos, S.
    Bellan, A.
    Dallorso, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S222 - S222
  • [36] A Phase II Clinical Trial to Explore Various Endpoints and Their Timings for GCSF-Mobilized CD34+Cell Therapy in No-Option Patients with Critical Limb Ischemia
    Kawamoto, Atsuhiko
    Fujita, Yasuyuki
    Kinoshita, Makoto
    Furukawa, Yutaka
    Okada, Yukikatsu
    Matsubara, Yoshihiro
    Fukushima, Masanori
    Asahara, Takayuki
    CIRCULATION, 2012, 126 (21)
  • [37] Statin therapy and bone marrow CD34+cell frequency in type 2 diabetes mellitus: A cross-sectional study
    Lei, Lei
    Zhang, Xiyang
    Mao, Yuanjie
    Lin, Xin
    Yang, Liyan
    Li, Yufang
    Dong, Song
    Wang, Yizhong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 175 (01) : 214 - 216
  • [38] A Pilot Study of Eltrombopag Plus G-CSF for Human CD34+Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
    Laubach, Jacob P.
    Freedman, Revital
    Redd, Robert A.
    Tippy, Mason
    Cummings, Kristen
    Dipietro, Heidi
    Naik, Nivisha Upendra
    Nicol, Kelly
    Richardson, Paul G.
    Najita, Julie
    Berliner, Nancy
    BLOOD, 2016, 128 (22)
  • [39] Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
    Henry, Timothy D.
    Losordo, Douglas W.
    Traverse, Jay H.
    Schatz, Richard A.
    Jolicoeur, E. Marc
    Schaer, Gary L.
    Clare, Robert
    Chiswell, Karen
    White, Christopher J.
    Fortuin, F. David
    Kereiakes, Dean J.
    Zeiher, Andreas M.
    Sherman, Warren
    Hunt, Andrea S.
    Povsic, Thomas J.
    EUROPEAN HEART JOURNAL, 2018, 39 (23) : 2208 - 2216
  • [40] SAFETY AND EFFICACY OF INTRA-RENAL ARTERIAL AUTOLOGOUS CD34+CELL TRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE II CLINICAL TRIAL
    Yang, Chihchao
    Li, Yi-Chen
    Yip, Honkan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 484 - 484